home · filing · 0000849146-22-000020
8-K
filed March 11, 2022, 6:59 PM ET
ticker LFVN
CIK 0000849146
leadership
confidence high
sentiment neutral
materiality 0.50
LifeVantage Chief Sales Officer Justin Rose departs effective March 7, 2022
Lifevantage Corp
Justin Rose's employment as Chief Sales Officer ended March 7, 2022.
No reason for departure was disclosed in the filing.
No replacement or interim appointment has been announced.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Departed
Justin Rose
Chief Sales Officer
Effective 2022-03-07
Filed March 11, 2022, 6:59 PM ET
The employment of Justin Rose, LifeVantage Corporation’s Chief Sales Officer, ended effective on March 7, 2022.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Justin Rose departed as Chief Sales Officer at Lifevantage Corp.
Action ended
Role Chief Sales Officer
Exact text from the filing
The employment of Justin Rose, LifeVantage Corporation’s Chief Sales Officer, ended effective on March 7, 2022.
View on SEC.gov
Source: SEC EDGAR
accession 0000849146-22-000020
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.